Interferon-β deficiency at asthma exacerbation promotes MLKL mediated necroptosis

Samuel C Cerps1, Mandy Menzel1, Irma Mahmutovic Persson1

  • 1Unit of Respiratory Immunopharmacology, Department of Experimental Medicine, Lund University, Lund, Sweden.

Scientific Reports
|March 11, 2018
PubMed

Insights

Defective interferon-beta (IFN-β) production worsens asthma exacerbations by increasing necroptotic cell death. This study shows reduced IFN-β augments cell death markers during viral-induced asthma attacks.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • Asthma exacerbations are linked to rhinovirus and defective antiviral interferon (IFN)-β production.
  • Elevated lung lactate dehydrogenase (LDH) suggests cell necrosis during these exacerbations.

Purpose of the Study:

  • To investigate the role of reduced lung IFN-β in contributing to necrotic cell death during asthma exacerbations.
  • To explore the mechanisms of cell death, including necroptosis, in a mouse model of viral-induced asthma exacerbation.

Main Methods:

  • Induction of airway inflammation using house dust mite (HDM) in wild-type and IFN-β knockout mice.
  • Viral stimulus (double-stranded RNA) was administered to induce exacerbation.
  • Analysis of bronchoalveolar lavage fluid (BALF) for cell death markers (LDH, cleaved caspase-3, cleaved PARP, RIP-3, pMLKL).

Main Results:

  • HDM plus dsRNA challenge increased BALF LDH, apoptotic, and necroptotic markers (RIP-3, pMLKL) compared to controls.
  • Absence of IFN-β exacerbated cell death, significantly increasing BALF LDH and pMLKL expression during exacerbation.
  • Viral stimulus-induced exacerbation increased cell death markers in mouse lungs.

Conclusions:

  • Deficient IFN-β production plays a critical role in augmenting necroptotic cell death during viral-induced asthma exacerbations.
  • These findings suggest a novel mechanism linking impaired antiviral response to severe asthma pathology.
  • Targeting IFN-β pathways may offer therapeutic strategies for managing asthma exacerbations.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K